Skip to main content

Table 2 Description and comparison of states of health in assessments at M6 and M12

From: Fatigue and quality-of-life in the year following SARS-Cov2 infection

  M6
n = 120
M12
n = 120
Re-hospitalisation   
 Yes (%) 4 (3.33) 10 (8.33)
Experienced dyspnoea   
 Yes (%) 47 (39.87) 50 (41.67)
Experienced palpitations   
 Yes (%) 19 (15.83) 19 (15.83)
Chest pains   
 Yes (%) 19 (15.83) 18 (15)
Cough   
 Yes (%) 24 (20.17) 25 (20.83)
Headaches   
 Yes (%) 24 (20.17) 25 (20.83)
Arthromyalgia   
 Yes (%) 49 (41.88) 56 (46.67)
Diarrhoea   
 Yes (%) 19 (16.24) 20 (16.67)
Other symptoms*   
 Yes (%) 42 (35.00) 54 (45.00)
Systolic blood pressure   
Median [Q1–Q3] 132.00 [120.00–145.0] 133.00 [120.00–149.00]
 ≤ 140 mmHg (%) 77 (65.81) 71 (61.21)
 > 140 mmHg (%) (high blood pressure) 40 (34.19) 45 (38.79)
Heart rate (bpm)   
Median [Q1–Q3] 76.00 [67.00–88.00] 78.00 [66.00–85.00]
mMRC rating   
 0 (%) 45 (37.50) 42 (35.59)
 1 (%) 37 (30.83) 36 (30.51)
 2 (%) 17 (14.17) 19 (16.10)
 3 (%) 12 (10.00) 12 (10.17)
 4 (%) 9 (7.50) 9 (7.63)
Anxiolytics   
 Yes (%) 11 (9.32) 15 (12.50)
BMI   
Median [Q1–Q3] 28.00 [25.00–32.00] 28.00 [25.00–32.00]
 ≥ 40 kg/m2 (%) 9 (7.56) 7 (5.83)
 < 40 kg/m2 (%) 110 (92.44) 113 (94.17)
SpO2   
Median [Q1–Q3] 97.00 [96.00–98.00] 96.00 [94.00–97.75]
 < 94% (%) 2 (1.74) 6 (5.26)
 > 94% (%) 113 (98.26) 108 (94.74)
Hypnotics   
 Yes (%) 7 (5.93) 15 (12.5)
Antidepressants   
 Yes (%) 11 (9.32) 17 (14.17)
Anticoagulants   
 Yes (%) 19 (16.10) 18 (15.00)
Asthenia   
 Yes (%) 69 (57.50) 69 (57.50)
FSS mean score   
 > 4 (%) 39 (35.65) 51 (43.97)
 < 4 (%) 72 (64.35) 65 (56.03)
 Mean ± SD 3.42 ± 1.87 3.60 ± 1.97
SF12 score   
 PCS12: mean ± SD 42.85 ± 10.03 42.18 ± 9.60
 MCS12: mean ± SD 46.70 ± 7.57 47.13 ± 6.43
  1. BMI Body Mass Index, SpO2 peripheral oxygen saturation
  2. *Anxiety, problems of concentration, decreased visual acuity, panic attacks, rhinorrhea, fatigue, insomnia, cognitive decline, dyspnoea upon effort, hair loss vertigo, headaches, diarrhoea, constipation, dysgeusia